Lisa Burns: Cystic Fibrosis NZ chief executive says provisional agreement for Trikafta funding is a miracle

Funding for a Cystic Fibrosis drug is being described as a miracle. A provisional agreement's been made between Pharmac and Vertex to fund the drug Trikafta for those with the condition aged six and over. The drug buying agency estimated it could give those people up to 27 more years of full health when compared with supportive care. Cystic Fibrosis Chief Executive Lisa Burns told Tim Dower they know from other countries the drug's incredible life-changing effects. “There is a different level of quality of life, there is the ability to put weight on, there’s the ability to work and attend school.” LISTEN ABOVESee omnystudio.com/listener for privacy information.